Question-and-Answer Session
Operator
Thank you, sir. (Operator Instructions) We’ll take our first question from Dave Turkaly from SIG.
Dave Turkaly - SIG
Thanks a lot. When we look at the new products that you guys have slated for this year, I know you’ve discussed some of them on the call, but in terms of the timeline in them, maybe which you think could contribute most quickly as we progress through 2009 in terms of overall size?
Brian Hutchison
Dave this is Brian. We haven’t talked in detail about any specific product launches; there are a number of them. If I would have to say what’s most critical, we would say on the BGS side, we would call that critical to accelerate the products with our new partners in those spaces throughout the year, as well as all of the spine grafts that are on the joint board, those are all line extension type things that we hope to get out.
In the sport side, we’ll be talking at academy live about some of the new things that we’ve been working on, but certainly our Fresh OC program, accelerating growth there, our cartilage plug, as well as the new product that we’re talking about called matrix HD, which is actually a membrane technology for sports; we’ll be talking about that as well.
Dave Turkaly – SIG
Okay and then I know that it’s tough giving all your partners, but to know their inventory levels and how they adjust the orders quarter-to-quarter. Again we’ve seen a couple of quarters where there might have been that impact in (Inaudible); the distributor might be tightening what they carry in inventory. Do you think we’ve stabilized now for that impact on the most part or do you have any kind of programs that you guys are into with some of these partners to kind of smooth that out let’s say as we look into 2009?
Tom Rose
Dave, I think the inventory distributors probably in Q3 and Q4, we saw adjustments most of them downwards and as a source again here in 2009, we think the inventory levels at distributors are fairly optimal. I don’t think we’re going to see a lot of fluctuations impacting our quarterly revenues this year. On the other hand, the one thing we’ll see, I think that will still be an issue for us in this year, but on a positive basis is launches from quarter-to-quarter can impact the levels, whether its spine or surgical specialties.
- To read the full transcript on Seeking Alpha, click here »
